Skip to main content
Medical information Clinical review pending

Genetic Testing

PSMB8 Gene Autoinflammation Lipodystrophy and Dermatosis Syndrome Genetic Test

Genetic test using Next-Generation Sequencing (NGS) to analyze the PSMB8 gene, identifying mutations linked to autoinflammatory syndromes, lipodystrophy, and dermatosis. Helps in diagnosis and personalized treatment.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card.
Results
Confirm with the laboratory before booking.
Preparation
A clinical history of the patient is required. A genetic counseling session is recommended prior to testing to discuss the test and create a family pedigree chart.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the PSMB8 Gene Autoinflammation Lipodystrophy and Dermatosis Syndrome Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of lipodystrophy or autoinflammatory syndromes.
  • ✓Presence of unusual skin lesions.
  • ✓Metabolic issues.
  • ✓Recurrent infections.
  • ✓Suspected genetic predisposition to related disorders.
02

In plain language

What this test helps you understand

This test helps identify specific genetic mutations in the PSMB8 gene associated with autoinflammatory syndromes, lipodystrophy, and dermatosis. This information can aid in confirming a diagnosis, understanding the underlying cause of symptoms, and guiding personalized treatment approaches.
The PSMB8 Gene Autoinflammation Lipodystrophy and Dermatosis Syndrome NGS Genetic DNA Test is a specialized diagnostic tool utilizing Next-Generation Sequencing (NGS) technology to examine the PSMB8 gene. This test is designed for individuals potentially at risk for autoinflammatory syndromes associated with lipodystrophy and dermatosis. Understanding genetic predispositions is key for timely intervention and developing personalized treatment strategies.

This genetic test specifically looks for mutations within the PSMB8 gene that have been associated with various skin and immune system disorders. Identifying these mutations can help healthcare providers understand the root causes of a patient's symptoms and guide appropriate medical management.

Individuals with a family history of lipodystrophy or autoinflammatory syndromes, patients presenting with symptoms like unusual skin lesions, metabolic problems, or frequent infections, and those seeking to understand their genetic risk for these conditions may benefit from this test.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationA clinical history of the patient is required. A genetic counseling session is recommended prior to testing to discuss the test and create a family pedigree chart.
SampleBlood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card.
MethodologyNext-Generation Sequencing (NGS) of the PSMB8 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes specific mutations within the PSMB8 gene. It may not detect all possible genetic variations associated with the conditions. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The PSMB8 gene provides instructions for making a protein that is part of a complex called the immunoproteasome. This complex helps break down proteins within cells, playing a role in the immune system.
These are conditions characterized by recurrent episodes of inflammation without evidence of infection or autoimmunity. They often involve the immune system.
Lipodystrophy refers to conditions where there is an abnormal or degenerative condition of the body's adipose tissue (fat).
Insurance coverage varies. Please check with your insurance provider regarding coverage for genetic testing.
A healthcare professional, often a geneticist or specialist, will interpret the results in the context of your clinical history and family history.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp